Atul Pande - Sep 30, 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Director
Signature
/s/ Eva Renee Barnett, attorney-in-fact for Atul Pande
Stock symbol
IMVT
Transactions as of
Sep 30, 2022
Transactions value $
$84,000
Form type
4
Date filed
10/4/2022, 04:27 PM
Previous filing
Aug 19, 2022
Next filing
Apr 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Purchase $84K +15K +300% $5.60 20K Sep 30, 2022 By Trust F1, F2
holding IMVT Common Stock 83K Sep 30, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.59 - $5.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
F2 These shares are owned by a trust (the "Trust"). Certain members of the Reporting Person's immediate family are beneficiaries of the Trust.
F3 Represents the number of shares underlying restricted stock units awards ("RSUs").